Valuation China Resources Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. 04:08:16 2026-10-16 EDT			5-day change	1st Jan Change
4.605 ^HKD	-2.23%		+5.14%	+3.48%

10-01	China Resources Pharmaceuticals Needs More Than Distribution Scale to Win
09-01	China Resources Pharma Unit's Bond Program Registration Accepted in China	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,303	39,705	32,229	35,810	27,957	28,931	-	-
Change	-	78.03%	-18.83%	11.11%	-21.93%	3.48%	-	-
Enterprise Value (EV) ¹	61,337	73,426	71,468	90,725	90,801	78,166	71,459	59,152
Change	-	19.71%	-2.67%	26.95%	0.08%	-13.92%	-8.58%	-17.22%
P/E	5.92x	9.58x	7.76x	10x	6.12x	5.91x	5.54x	5.28x
PBR	0.44x	0.8x	0.32x	0.34x	0.48x	0.45x	0.41x	0.37x
PEG	-	1x	44.15x	-0.7x	0.2x	0.82x	0.83x	1.06x
Capitalization / Revenue	0.09x	0.16x	0.12x	0.13x	0.09x	0.09x	0.08x	0.08x
EV / Revenue	0.26x	0.29x	0.27x	0.33x	0.3x	0.24x	0.21x	0.17x
EV / EBITDA	4.83x	4.38x	4.65x	5.47x	4.73x	3.93x	3.32x	2.85x
EV / EBIT	6.22x	5.39x	5.98x	6.98x	6.23x	4.85x	4.11x	3.37x
EV / FCF	5.88x	7.47x	5.49x	5.73x	4.37x	-28.8x	9.74x	6.56x
FCF Yield	17%	13.4%	18.2%	17.5%	22.9%	-3.48%	10.3%	15.3%
Dividend per Share ²	0.15	0.16	0.1669	0.1445	0.2203	0.2035	0.2202	0.218
Rate of return	4.23%	2.53%	3.25%	2.54%	4.95%	4.42%	4.78%	4.73%
EPS ²	0.6	0.66	0.6612	0.5677	0.7268	0.7794	0.8312	0.8725
Distribution rate	25%	24.2%	25.2%	25.5%	30.3%	26.1%	26.5%	25%
Net sales ¹	236,806	254,106	265,229	275,999	306,131	327,819	340,757	352,428
EBITDA ¹	12,690	16,775	15,382	16,601	19,202	19,905	21,499	20,777
EBIT ¹	9,868	13,623	11,952	13,005	14,567	16,129	17,398	17,536
Net income ¹	3,769	4,147	4,178	3,589	4,594	4,824	5,178	5,377
Net Debt ¹	39,035	33,720	39,238	54,915	62,844	49,235	42,528	30,221
Reference price ²	3.550	6.320	5.130	5.700	4.450	4.605	4.605	4.605
Nbr of stocks (in thousands)	6,282,510	6,282,510	6,282,510	6,282,510	6,282,510	6,282,510	-	-
Announcement Date	3/29/22	3/30/23	3/26/24	3/26/25	3/24/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED	5.91x	0.24x	3.93x	4.42%	3.69B
ELI LILLY AND COMPANY	35.96x	12.96x	27.14x	0.55%	1,120B
JOHNSON & JOHNSON	37.4x	6.3x	17.74x	2.09%	616B
ABBVIE INC.	36.43x	8.36x	17.24x	2.43%	504B
ROCHE HOLDING AG	20.46x	4.99x	12.38x	2.64%	367B
MERCK & CO., INC.	106.52x	5.95x	25.12x	2.33%	360B
NOVARTIS AG	21.18x	5.54x	13.63x	2.88%	288B
ASTRAZENECA PLC	21.7x	4.38x	12.55x	2.01%	258B
AMGEN INC.	27.46x	7.06x	12.64x	2.33%	234B
GILEAD SCIENCES, INC.	-45.63x	6.99x	27.07x	2.11%	194B
Average	26.74x	6.28x	16.94x	2.38%	394.46B
Weighted average by Cap.	34.70x	8.19x	20.02x	1.84%